Manhattan Scientifics Inc. Issues Shareholder Update on its Nano-Metals Technology
Manhattan Scientifics Inc. (OTCQB: MHTX), today announced that the company is involved in discussions to license its nano-metals
technology and related intellectual property to a medical industry metals manufacturer.
Manhattan Scientifics has to date received $500,000 good faith and machinery payments from the sale of equipment to the
manufacturer.
Discussions with this manufacturer have been on-going for an extended period. The closing of such agreement is subject to
continued due diligence, drafting a definitive agreement and approval of our Board of Directors. There can be no guarantee that we
will satisfactorily conclude a commercial arrangement with this manufacturer.
About Manhattan Scientifics, Inc.
Manhattan Scientifics Inc. (www.mhtx.com)
is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of transformative
technologies.
Forward-looking statement
This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties
that could cause the Company's actual results to differ materially from those projected in such forward-looking statements.
Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk
spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no
obligation to publicly update or revise any forward-looking statements.
Manhattan Scientifics, Inc.
Manny Tsoupanarias, 917-688-4158
Manny@mhtx.com
Marvin Maslow
Marvin@MHTX.com, 917-923-3300
View source version on businesswire.com: https://www.businesswire.com/news/home/20181212005182/en/